News

FDA Upheaval Pushes Some Biotech Firms to Plan Early Trials Out of US
The FDA did not respond to a request for comment. U.S. Health Secretary Robert F. Kennedy Jr. has said that the agency's ...
Feds recommend pausing vaccine for mosquito-borne disease chikungunya in people over 60
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
Stocktwits on MSN1d
Moleculin Biotech Gets EMA Nod For Leukemia Trial: Retail Feels Bullish On ‘Low And Slow’ Setup
Retail chatter around Moleculin Biotech surged on Monday after the company said the European Medicines Agency had approved ...
Research raises concerns about the safety of long-term ADHD medication treatment in children
A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance ...
The Manila Times2d
Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin” or the "Company”), a late-stage pharmaceutical company with a broad ...
FDA Approves Merck's Kidney Cancer Drug For Rare Type Of Neuroendocrine Tumors
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for ...
MedPage Today on MSN5d
Drug Used by Trump Has Suicide Risk; FDA's 'Aggressive' AI Rollout; 1K Measles Cases
Thoughts of suicide was confirmed as a side effect of finasteride (Propecia, Proscar), the European Medicines Agency (EMA) ...
BioSpace2d
FDA, EU Flag Safety Issues With Valneva’s Chikungunya Vaccine
The FDA and CDC have also recommended pausing the use of Ixchiq in seniors 60 years and older while safety investigations are ...
Fierce Pharma2d
FDA, CDC call for pause of chikungunya shot rollout in older adults
On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...
News Medical on MSN9h
New study raises concerns about the safety of long-term ADHD medication treatment in children
It is worrying that reliable data on the safety of these medicines is only available for one year of follow-up. After all, we are talking about children at a very sensitive stage of development.” — ...